Administration, MetronomicCyclophosphamideAntineoplastic Combined Chemotherapy ProtocolsAngiogenesis InhibitorsAntineoplastic Agents, AlkylatingDrug Administration ScheduleNeovascularization, PathologicXenograft Model Antitumor AssaysAntineoplastic AgentsMice, SCIDAdministration, OralChemotherapy, AdjuvantDose-Response Relationship, DrugEndothelial CellsCombined Modality TherapyTreatment OutcomeCisplatinDoxorubicinNeoadjuvant TherapyDisease-Free SurvivalBreast NeoplasmsEtoposideSurvival AnalysisNeoplasm StagingLung NeoplasmsSurvival RatePrognosisMethotrexateCarboplatinPaclitaxelTime FactorsVinblastineNeoplasmsInduction ChemotherapyNeoplasm Recurrence, LocalTaxoidsIfosfamideDrug Resistance, NeoplasmDeoxycytidineAntimetabolites, AntineoplasticFollow-Up StudiesBleomycinOrganoplatinum CompoundsCytarabineProspective StudiesAnthracyclinesSalvage TherapyNeutropeniaCarcinoma, Non-Small-Cell LungVomitingNauseaNeoplasm MetastasisChemotherapy, Cancer, Regional PerfusionInfusions, IntravenousActivities of Daily LivingOvarian NeoplasmsAntineoplastic Agents, PhytogenicRadiotherapy DosageAdenocarcinomaClinical Trials as TopicTransplantation, AutologousLymphoma, Non-HodgkinRadiotherapyTesticular NeoplasmsRadiotherapy, AdjuvantHodgkin DiseaseAntibiotics, AntineoplasticColorectal NeoplasmsDouble-Blind Method